Skip to main content
Equibles
NRIX logo

NRIX · Nurix Therapeutics, Inc.

Track NRIX — free

Use NRIX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about NRIX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$26.72 -0.33 (-1.22%) At close · Aug 21
Market Cap
$2.77B
Shares
103.78M

Nurix Therapeutics, Inc. Earnings Call Transcripts

Every quarterly earnings call for Nurix Therapeutics, Inc. (NRIX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲61.2% $11.43M −$45.40M '22 Q2 22-07-07 ▼8.3% $6.78M −$46.72M '22 Q4 23-02-09 ▼60.6% $12.09M −$44.55M '24 Q2 24-07-11 ▼12.4% $13.28M −$58.55M '24 Q4 25-01-13 LATEST ▼79.5% $9.04M −$89.53M '26 Q2 26-07-09
Earnings call
FY26 · Q2
2026-07-09
Earnings conference call (announced in 8-K)
Revenue
$9.04M
▼ 79.5% YoY
Diluted EPS
$-0.81
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-04-13
25th Annual Needham Virtual Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY24 · Q4
2025-01-13
Nurix Therapeutics, Inc. Q4 FY2024 Earnings Call
Revenue
$13.28M*
▼ 12.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q2
2024-07-11
Nurix Therapeutics, Inc. Q2 FY2024 Earnings Call
Revenue
$12.09M
▼ 60.6% YoY
Diluted EPS
$-0.71
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-09
Nurix Therapeutics, Inc. Q4 FY2022 Earnings Call
Revenue
$6.78M*
▼ 8.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2022-07-07
Nurix Therapeutics, Inc. Q2 FY2022 Earnings Call
Revenue
$11.43M
▲ 61.2% YoY
Diluted EPS
$-1.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–7 of 7 earnings calls
Key facts CIK 1549595 CUSIP 67080M103 13F (30d) 202 filings 195 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)